Le Lézard
Classified in: Health
Subjects: NPT, CHI, PER, WOM, DEI

Judith Robb-McCord Joins March of Dimes As Vice-President of Global Impact


ARLINGTON, Va., Sept. 16, 2021 /PRNewswire/ -- March of Dimes, the nation's leading nonprofit fighting for the health of all moms and babies, today announced the appointment of Judith Robb-McCord, as Vice President of Global Impact, effective September 20, 2021. Robb-McCord will position the organization as a leader in global maternal and infant health programs, policy, education research and advocacy while identifying areas of alignment between domestic and global initiatives and opportunities for growth and greater impact.

"The U.S. is facing an ongoing maternal and infant health crisis and in 2021 we are still among the most dangerous developed nations for a woman to give birth," said Dr. Zsakeba Henderson, Senior Vice President and Deputy Chief Medical and Health Officer at March of Dimes. "We are excited to welcome Judith to the team. Her passion for building and implementing mission focused programs around the world will help us increase global understanding of preterm birth and other causes of poor maternal and infant outcomes, including disparities in those outcomes."

Prior to joining March of Dimes, Robb-McCord served as Vice President of Technical Leadership and Support at Project Concern International and Global Communities. Robb-McCord has nearly 30 years of experience as a global development expert across the U.S. government and non-governmental organizations including Jhpiego, PATH and USAID. As an expert in advancing collaborative investments in maternal and infant health, Robb-McCord will contribute to policy development and implementation in the area of maternal and infant global maternal health to advance leadership of March of Dimes in the global health community. 

"March of Dimes is the leading organization working to end the maternal and infant health crisis here in the U.S. and I am excited to join the team," said Robb-McCord. "I look forward to working with international public health agencies and the global health community to expand measurable progress for growth and greater impact so that all moms receive the care they need and all babies get the best start at life."

Robb-McCord holds a Bachelor of Arts degree from Brigham Young University, a Master's degree in African Area Studies and a Masters of Public Health from University of California, Los Angeles. She is highly respected in her field and has been invited to speak by the World Health Organization and Devex Forum and is a contributing author on several peer-reviewed journal articles. As a member of many world-renowned networks and coalitions including the Global Respectful Maternity Care Council and TogetHER for Health, Robb-McCord's experience as a leader of high performing and diverse teams will continue to advance global health metrics, promote innovative and evidence-based programming to catalyze action for priority public health impact.

ABOUT MARCH OF DIMES

March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every mom and baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we're there for every family?those who had first-hand hardships, those celebrating their health and those just trying to start their families. For more information go to marchofdimes.org or nacersano.org, and visit shareyourstory.org for comfort and support. Find us on Facebook and follow us on Instagram and Twitter.

SOURCE March of Dimes Inc.


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: